Abbott Laboratories vs Medtronic
Abbott Laboratories is the larger business, with $44.33bn of revenue in fiscal 2025 against $36.36bn for Medtronic (1.2 times as much). Medtronic grew faster (8.4% against 5.7%). Abbott Laboratories kept more of each dollar of sales as profit: a net margin of 14.7% against 13.2%.
| Latest fiscal year | Abbott LaboratoriesABT, 2025 | MedtronicMDT, 2026 |
|---|---|---|
| Revenue | $44.33bn | $36.36bn |
| Revenue growth | 5.7% | 8.4% |
| Net income | $6.52bn | $4.80bn |
| Operating margin | 18.2% | — |
| Net margin | 14.7% | 13.2% |
| Return on equity | 13.1% | 9.8% |
| Free cash flow | $7.39bn | $5.43bn |
| Cash | $8.52bn | $1.95bn |
| Total debt | $12.93bn | $28.13bn |
| Debt to equity | 24.8% | — |
| Dividend per share | $2.40 | $2.84 |
| Dividend yield | 2.2% | 2.9% |
| Share buybacks | $893m | $1.03bn |
| Employees | 115,000 | 95,000 |
| Market value | $190.32bn | $126.55bn |
| Price vs our value range | Above our value range | Within our value range |
| Moat score | 72 (Strong) | 86 (Strong) |
| Insider trades, 12 months | 6 buys, 11 sales | 0 buys, 18 sales |